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Abstract
Anthelmintics used in animals to combat parasitic infections are mainly excreted 
in manure and cause negative effects on the environment and decomposers. 
Nematodes are associated with the rhizosphere; some are gastrointestinal parasites 
of animals, and others regulate insects and other arthropods (entomopathogenic 
nematodes) and are considered beneficial. The habitat and the similarities that exist 
among them give the opportunity to use nematodes as a biological model. The avail-
ability of target organisms is not always feasible; therefore, experimental studies 
with models similar to those of the target organisms are a possibility. In veterinary 
clinics, the study of drug susceptibility is a fundamental tool to monitor the devel-
opment of resistance. To conserve the biodiversity of the environment, it is neces-
sary to make adequate use of anthelmintics, avoid resistance to these pesticides and 
prevent the used products from damaging populations of beneficial organisms.
Keywords: Rhizosphere, parasites, intestinal, entomopathogens, anthelmintics, 
resistance
1. Introduction
Nematodes in nature show astonishing biodiversity since only approximately 
30,000 species have been described, but it is estimated that there are a million or 
more species of nematodes worldwide. Nematodes generally have a long, narrow 
and thread-like body (‘nema’ from the Greek ‘thread’), not segmented like earth-
worms. Its body is basically tubular, and the intestine and gonad are surrounded by 
the wall of the body with its dorsal and ventral longitudinal muscles, epidermis and 
cuticle. Between the inner and outer tubes, there is a pressurised cavity filled with 
fluid that acts as a hydrostatic skeleton, all of which allows the nematodes to move 
in sinusoidal waves. The morphological diversity in this group is restricted and 
much lower than that of other arthropods or vertebrates. All nematodes go through 
three or four larval stages, and at the end of each stage, a new cuticle is synthesised, 
and the previous cuticle is moulted. The nematode species are very diverse, and the 
most obvious differences are observed in size, which varies from fractions of a mil-
limetre to several metres, cuticular decorations and especially feeding structures. 
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The mouth of nematodes can be a simple tube, or it can be decorated with a perfo-
rating stylet (in plant parasites and fungal feeders) or with teeth that can cut, tear 
or bite in predatory species such as Mononchus and in some intestinal parasites such 
as Strongylus [1].
Nematodes are also the most numerous group of parasites of animals and 
humans and are widely distributed in a variety of habitats. Some are free-living, 
while others are in some part of their life cycle parasites of plants and vertebrates or 
invertebrates [2]. Parasitic nematodes of animals have great economic importance; 
due to the high frequency with which they occur, they are generally chronic and 
most interfere with good growth. They can be located in most organs, mainly in the 
digestive tract, have a direct or indirect life cycle, and some are zoonotic [3].
2. Anatomy
The cuticle is a noncellular, flexible and elastic structure that generally has 
externally arranged rings; however, since the cuticle is not visible, it has a smooth, 
shiny appearance and is secreted by the layer of cells that are immediately below, 
that is, the hypodermis (Figure 1). The cuticle is formed by several layers whose 
number and thickness vary according to the species in question and is composed of 
proteins such as albumin and glycoproteins [4].
The hypodermis is a thin layer of four tubular thickenings, called the dorsal 
cord, two lateral and one ventral. It contains cells that secrete the layers of the 
cuticle. The muscular system is composed of two types of muscles, specialised and 
nonspecialized or somatic, which occupy a position close to the hypodermis of the 
areas between the cords, forming a single layer of cells, which has an important role 
in body movements [5].
The specialised muscles are found in several positions and have important func-
tions, such as the oesophageal muscles in the wall of the oesophagus, the intestinal 
muscles in the wall of the intestine, the dilator and compressor muscles of the 
Figure 1. 
Nematode cross section (c) cuticle, (cd) dorsal field, (cl) lateral field, (cm) muscle cell, (cv) ventral field, (i) 
intestine, (o) ovary, (u) uterus.
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anus, the copulatory muscles, those of the copulatory bursa, of the spicules, of the 
gubernaculum and vulva [4].
Cordero del Campillo et al. [6] described the anatomy of nematodes in detail 
regarding the digestive system of nematodes, indicating that it is elongated and has 
a sac-like shape; it is composed of different organs (Figure 2). The mouth is located 
in the subdorsal or ventral apex, and the primitive model is made up of six lips with 
two papillae each distributed in two circles (internal and middle) and a third or 
external circle of four papillae and two lateral amphids, although there are extensive 
variations in morphology and position. The oral cavity or orifice is a dilation in 
which hooks or teeth are found both in the cuticular walls in the oral capsule or in 
the bottom of the cavity. The oesophagus is a radiated muscular organ covered by 
a thick cuticle, and the muscles that occupy the oesophageal lumen contain three 
glands, which produce enzymes for its digestive function (Figure 3). The intestine 
Figure 2. 
Schematization of (a) digestive system, (b) excretory system, (c) nervous system.
Figure 3. 
Different types of nematode oesophagus; (a) rhabditoid, (b) strongyloid, (c) filariform, (d) oxyuride, (e) 
trichuroid.
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is cylindrical in shape and is composed of a basal lamina and a single cell epithelium 
with a nonmuscular wall covered by microvilli (Figure 2). Finally, the rectum is 
found as an invagination of the cuticular lining that in males gives rise to the cloaca; 
in some species, it also has glands. In addition to the functions of absorption and 
defecation of the rectum, it fulfils other functions as an organ of secretion.
The excretory system contains two unbranched lateral tubes that are part of the 
lateral cords of the hypodermis. The excretory duct comprises the transverse canal 
to the excretory pore, which generally encompasses the cephalic and cervical region 
of the nematode.
The nervous system of nematodes is formed by the circumoesophageal ring, 
which contains ganglia and surrounds the oesophagus, with numerous longitudinal 
nerves (Figure 2). On the dorsal and ventral lines of the body of the nematodes 
are two of the six short nerves that pass through the anterior part of the body, and 
another six long nerves pass to the posterior end of the body, likewise a shorter 
nerve in the ventral line, and the longest in the dorsal line and two small ones in 
each lateral line. The main nerves emit nerve fibres that can become entangled 
throughout the body and rejoin these nerves or follow other routes. In general, the 
sensory organs of parasitic nematodes are less developed than those of nonparasitic 
nematodes since parasitic life degenerates and atrophies the sensory organs. For 
these, if we can find the oral papillae, a pair of cervical papillae, and amphidal 
papillae located in the anterior end, in the posterior end of the body of the male, we 
can find the genital papillae and other called phasmids in the posterior end of males 
and females, we can also find an anal ganglion.
The reproductive organs of nematodes are filiform, whitish, long and spirally 
wound, and their apical end is blind. They continue with long tubes of similar 
morphology that lead them to the genital cells to the outside. Both the ovaries and 
the testicles begin as thin threads and are transformed into a central cord, and the 
surrounding genital cells are later transformed into genital ducts. The male has 
only one testicle and a vas deferens through which sperm discharge, a seminal 
vesicle where sperm are stored, and an ejaculatory duct that ends in the cloaca. The 
testes of most nematodes are of the telegonic type; we also found spermatogonia 
that extend from the distal portion of the tube and complete along the walls of 
the central rachis. The spicules are the copulatory organs that are generally found 
in nematodes, which are elongated and filiform organs of varied dimensions. The 
spicules are formed in the dorsal sac of the cloaca and are formed by cuticular mate-
rial. The retractor and ejector muscles are responsible for supporting the spicules, 
and the gubernaculum is the accessory organ on which the spicules slide and are 
oriented into and out of the cloaca. Some species also have a caudal pouch, which 
helps the male attach himself onto the female, and those that do not have it have 
other cuticular structures, grooves and rough areas.
The female genital tract is formed by the ovary that goes through a maturation 
process where the oogonia begin in the germinal zone and end in the maturation 
zone. The oviduct is a short and narrow tube through which the oocytes pass, 
containing epithelial cells at its base. The seminal receptacle is widening at the 
beginning of the uterus where sperm are stored. The uterus has an epithelial layer, 
a basal lamina and muscular annular cells. The vagina is covered in its proximal 
part by a cuticle, and the vaginal opening is in the ventral medial line of the 
helminth. The reproductive system of females can be monodelphic, didelphic or 
polydelphic.
The eggs of the nematodes have a more or less oval shape, and depending on the 
species, they also vary in size and content. Generally, we find three layers: the lipid 
layer, the chitinous layer and the external or vitelline layer.
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3. Life cycle
Generally, parasitic nematodes are sexually reproduced; males produce sperm, 
and females produce ovules, which are fertilised after copulation. Embryonic 
development includes the stages of morula, blastula, gastrula, and tadpole where 
the embryo acquires its shape. The life cycle includes an egg stage, larval stages 
(three or four) and an adult stage. Between each larval stage, there is a moulting 
or change in the cuticle, which can be rigid or elastic and allow growth. Through 
enzymatic action, each larval stage is released from its envelope to reach the next 
stage, which may be preceded by lethargy. The life cycles may or may not have one 
or more intermediate hosts, and the eggs or larvae produced in the definitive host 
are not infectious, except for rare exceptions. Larval development need to reach 
the infective stage. In the direct cycles, this development occurs in wet soil, prairies 
or water. In the indirect cycles, the development up to the infective stage occurs in 
the intermediate host. In the direct cycle, infestation is usually orally through the 
ingestion of eggs or larvae; and in the indirect cycle, it can be orally through the 
ingestion of the intermediate host or arthropod bites [5].
Larval migration to reach the site where they reach sexual maturity can occur 
through the digestive, hepato-cardio-pulmonary or lymphatic-cardio-pulmonary 
tracts. The process in which a developmental stage reaches another host includes a 
complex system of relationships between the animal population and the environ-
ment, which vary in time and space. The influence of the environment is important 
with factors such as temperature, humidity, luminosity, winds, rainfall, types of soil, 
types of vegetation and seasonal variation. Direct sun rays and dehydration rapidly 
destroy the larval stages, and the temperature has a range in which the conditions are 
optimal; outside this range, the physiological process stops and can be destroyed [7].
4. Entomopathogenic nematodes
The entomopathogenic nematodes of the families Steinernematidae and 
Heterorhabditidae are obligate parasites of arthropods, which live in the soil and are 
ubiquitous and are used commercially to suppress insect pests that live in the soil in 
agricultural fields [8]. Their use is incipient in the veterinary field.
Nematodes of the Steinernematidae family are characterised by their mutu-
alistic association with bacteria of the genus Xenorhabdus. This family is cur-
rently comprised by two genera, Steinernema, with more than 70 species, and 
Neosteinernema, with a single species, N. longicurvicauda [1].
The family Heterorhabditidae consists of one genus, Heterorhabditis, with H. 
bacteriophora as the model and 17 other species described. These have a life cycle 
similar to that of nematodes in general, but the adults that result from infectious 
juveniles (IJs) are hermaphrodites. The eggs laid by the hermaphrodites produce 
juveniles that become males and females or IJ. Males and females mate and produce 
eggs that develop in IJ [1].
Natural entomopathogenic nematodes can suppress insects in a wide variety of 
ecosystems. Insects at any stage of life that come into contact with infested soil are 
potentially susceptible to infection, and persistent populations of entomopatho-
genic nematodes in agricultural systems can provide valuable assistance to produc-
ers by reducing the costs associated with the management of insect pests. Knowing 
the environments in which entomopathogenic nematodes persist successfully helps 
to conserve the natural populations of these insect pathogens that are potentially 
valuable for agricultural production [8].
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4.1 Isolation of entomopathogenic nematodes
Because entomopathogenic nematodes are found in the rhizosphere, moist 
soil must be sampled for their isolation; it must be sieved to keep it free of organic 
matter and placed in containers adding larvae of the last instar of greater wax moth 
Galleria mellonella (Linnaeus), which has the objective of being a trap insect to 
complete the isolation. G. mellonella larvae are susceptible to infection by entomo-
pathogenic nematode species [4].
The container with the soil and the larvae of G. mellonella is covered and inverted 
and incubated at 25 ± 1°C for seven days. After this time, the larvae and/or pupae are 
recovered and placed in Petri dishes with a double layer of wet filter paper to maintain 
a high relative humidity and favour the development of the infection [9–10].
Once nematode infection is observed on the dead larvae, it is transferred to a 
White trap, which helps to separate infectious juvenile nematodes [11]. With the 
result of this isolation, they reproduce again in other larvae of G. mellonella to make 
their identification and later use them for the necessary assessments.
5. Anthelmintics
Anthelmintics are drugs used in the treatment against parasitic diseases, and 
they continue to be the cornerstone of parasite control programmes in animals; 
however, their irrational use has led parasites to develop resistance [12].
Since the parasites are grouped into three categories, Nematoda, Cestoda and 
Trematoda, there are also three categories or groups of drugs that are available for 
their treatment. Nematocidal drugs against intestinal worms, hookworms, Ascaris 
and Strongyloides include piperazine, mebendazole, thiabendazole, pyrantel, 
ivermectin and diethylcarbamazine, among others. Antitrematodal drugs include 
praziquantel, bithionol sulfoxide, oxamniquine, and metrifonate. The third group of 
antihelminths are anticestodal drugs, such as niclosamide, which are applied against 
Taenia, Echinococcus and Diphyllobothrium. Levamisole is often prescribed as an anti-
parasitic drug against nematodes such as Ascaris and tricostrongyloid species [13].
The most commonly used anthelmintics, their mode of action and mechanism 
of excretion to the environment are listed in Table 1.
5.1 Mechanisms of excretion of some chemicals used as anthelmintics
Because there is a diversity of anthelmintics, only some of the currently most 
used will be described as an example of the studies that have been performed for 
each of the active ingredients available.
There are several pharmacokinetic cycles for anthelmintics in animals, from which 
it is derived that excretion varies; for example, thiabendazole follows an enterohepatic 
cycle, the amount that is absorbed is rapidly metabolised in the liver by hydroxyl-
ation, and its main metabolite is 5-hydroxythiabendazole, which is also metabolised 
by glucuronidation and sulfate formation. After 8 h of its administration, 90% of the 
drug is eliminated as a metabolite through the urine and 5% in the faeces. Five days 
after the last dosage, it was completely eliminated from the body [13].
The fenbendazole that is absorbed is metabolised (and vice versa) and converted 
into oxfendazole (active compound), fenbendazole sulfone, fenbendazole-2-amino-
sulfone and other minor metabolites. The drug that is not absorbed (most of it) 
is eliminated in faeces and the rest in urine and milk, where 0.3% of the applied 
dose is detected. In sheep, cattle, and pigs, 44 to 50% of the fenbendazole dose is 
excreted unchanged in the faeces and less than 1% in urine [32, 33].
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For closantel, its elimination is up to 75% in faeces and to a lesser amount in 
urine 0.57, 50% of the administered dose is eliminated in 50 to 85 hours, excreting 
up to 90% of the dose unchanged [27, 34].
Chemical group Drug Target/mode of action Main mechanism of 
excretion




















β-Tubulin inhibitor Urine and feces  
[16, 17]
Cyclooctadepsipeptides Emodepside LAT-1/SLO-1 inhibitor Urine and feces [18]
Imidazothiazoles Tetramisole*
Levamisole*






Glutamate- and GABA-gated 
chloride channels receptor 
agonist












Depolarization of the 
tegument. Rapid levels of 







Uncoupler of the oxidative 
phosphorylation
Urine and feces  
[23, 27]




Uncoupler of the oxidative 
phosphorylation




L-subtype nAChR agonist Urine and feces  
[23, 29, 30]
Note: The compounds which are marked with an asterisk are also used in humans.
Abbreviations: GABA, γ-aminobutyric acid; LAT-1, latrophilin-1; nAChR, nicotinic acetylcholine receptor; SLO-1, 
slowpoke potassium channel type 1.
Table adapted from Sepúlveda-Crespo et al. [31].
Table 1. 
Anthelmintics most commonly used for treatment in humans and veterinary medicine, mode of action and 
mechanisms of excretion to the environment.
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Regarding the complete cycle of pharmacokinetics in animals, ivermectin, 
for example, is a commonly used drug that has been developed by laboratories 
for its application by different routes (subcutaneous, oral and topical). The oral 
route shows lower bioavailability, but its values in plasma can last from seven to 
14 days, so in low doses (10–40 μg/kg/day), it can be very effective for the control 
of infestations by parasites (the intramuscular route is not recommended). The 
absorption processes show differences according to the routes of application 
and the species treated. Some oily preparations applied subcutaneously reach 
therapeutic concentrations of 80 to 90 days with a half-life of 36 hours [35]. It has 
a high volume of distribution with slight variations between species. Because it 
is a natural lipophilic substance, it is widely distributed in all tissues and tends to 
accumulate in adipose tissue. The highest concentrations are found in the liver, 
bile and skin, while the lowest concentrations are in the brain. It is poorly metabo-
lised in the body; therefore, a large part of the dose is excreted unchanged [22].
It has been detected that the gastric content has the highest concentration of 
the drug. On the other hand, it is concentrated in large amounts in the mucus 
and intestinal content, so it is feasible to recover a large amount in the faeces, 
regardless of its route of administration. Ivermectin metabolism is carried out by 
hydroxylation processes in the rumen, stomach or intestine, regardless of the route 
of administration. Its metabolites are 24-hydroxymethyl-H2B1a, and 24-hydroxy-
methyl-H2B1b is eliminated by bile, so large amounts are detected in faeces, 
although it is also excreted in urine (2%) and in milk. Faecal excretion represents 
90% of the total administered dose and in cattle up to 98% or more [35].
In horses, unlike ruminants, the absorption process is faster after oral administra-
tion than with subcutaneous administration, and although the injection results in a 
greater bioavailability, the oral route is preferred, since parenteral administration can 
produce local swelling and other adverse reactions. Plasma concentrations are higher 
and are reached more quickly in horses than in sheep, probably because the rumen 
delays absorption in ruminants. However, the half-lives of sheep in subcutaneous 
and oral application were 3.7 and 2.8 days, respectively, similar to those of sheep. In 
horses, the mean residence time is also longer after oral administration (4.2 days) and 
subcutaneous administration (3 days) and longer in donkeys (6.5 days), with a half-life 
of 7.4 days. In horses treated subcutaneously, most of the dose (90%) was excreted 
faecally in 4 days. The higher concentrations found in equine faeces compared to cattle 
faeces have been attributed to a lower production of more concentrated faeces [22].
Once in the environment, ivermectin can be rapidly degraded when exposed 
to sunlight. This photodegradation occurs in the presence of ultraviolet light and 
can occur between 0.5 and 23 days, a period in which it can affect living beings 
that have contact with the drug, such as earthworms, beetles, insects, fish and 
even humans [36]. If the meat or by-products of treated animals are consumed by 
humans, it usually constitutes a public health problem. The residual effect of the 
drug can be 10 to 12 weeks, and this is considered ideal for the control of ectopara-
sites, such as fleas, ticks or flies [35].
6. Tests to determine the resistance of parasitic nematodes of animals
6.1 In vitro
6.1.1 Larval motility test
The test was performed in a flat-bottomed cell culture plate; to facilitate the pro-
cedure, a 24-well plate was used. Nematodes are applied, and counts are performed 
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in each of the wells. Finally, the treatments are inoculated to avoid mortality due to 
inadequate management [37]. The plate was incubated at 25 ± 1°C for 24 hours in 
complete darkness, after which a second nematode count was performed to deter-
mine the living and dead individuals in each well [38].
6.1.2 Larval migration inhibition test
For the larval migration inhibition test, a migration system is used that allows 
the physical separation of IJ with motility of the immobile ones through a 25 μm 
polypropylene mesh filter. The diameter of the pores allows active larvae, but not 
dead larvae, to pass through the mesh. In a new plate, the mesh filter is placed in 
each well, and the total volume of each well is transferred from the plate used in the 
motility test. The samples are incubated for 24 hours at 25 ± 1°C in complete dark-
ness, and then the live and dead nematodes were counted [39].
6.2 In situ
6.2.1 Faecal egg count reduction
The egg counts of parasitic nematodes present in the excrement are considered 
the main test for parasite control because it has been shown that animals maintain 
relatively consistent levels of egg excretion over time.
In this technique, a suspension of faecal material is dispersed in a solution of 
higher density than the eggs of parasites (solution with common salt, 33% zinc 
sulfate, 35% magnesium sulfate, saturated sugar solution, sodium nitrate, etc.). 
The difference in specific gravity causes the eggs to rise to the surface or all float 
to the same level. The solution mixed with the excrement is allowed to settle, and 
most of the faecal particles will fall towards the bottom since their density is greater 
than that of the solution. This step is important for some parasitological diagnostic 
techniques but not for this test. Therefore, the procedure should be completed in 
the shortest possible time or regularly homogenise the mixture.
To achieve the procedure and determine the reduction of eggs per gram of 
excreted faeces, it is necessary to use the parasitological technique that uses the 
device called McMaster chamber where the number of eggs in a given amount of 
liquid (0.15 mL) is verified and then procedures to estimate the amount of parasitic 
nematode eggs per gram of excrement used initially are performed, this activity 
must be done before and after treatments with anthelmintics, and subsequently 








= ç ÷ç ÷
è ø
 (1)
This technique is commonly used in the initial tests when populations of chemi-
cally resistant nematodes are suspected.
7. Biological models used for the assessment of anthelmintics
There are many limitations to conducting experimental studies on parasitic 
nematodes to assess the anthelmintic potential of a new product or drug, both for in 
vitro studies and in vivo studies. The difficulties, among others, are the difficulty of 
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evaluating their activity in adult stages of parasitic nematodes kept outside the host, 
the cost of infection and sacrifice of experimental donor animals, and the impos-
sibility of obtaining large quantities of the stages of the nematodes under study., the 
cost of maintaining the hosts, labour, the total time of handling the animals, and 
the approval of different ethics committees, among others not listed [40–42].
Although there are problems because in vitro studies with biological models 
different from parasitic nematodes sometimes do not offer reliable results, the use 
of entomopathogenic nematodes can help to standardise studies or preliminary tests 
that allow establishing the correct methodology. as its use to determine the effect on 
nontarget species.
Of the nematodes commonly used as a biological model for the assessment of 
anthelmintic products in vitro is Caenorhabditis elegans, and in vivo assessments 
have used rodents when the parasite allows it [43–45]. It is essential to consider 
that both physical and biological differences between nematode species can be a 
limitation for the assessment of new drugs developed to inhibit specific parasitic 
stages; therefore, this characteristic should be considered when using a nontarget 
species. (C. elegans, entomopathogenic nematodes, among others) for assessments. 
Currently, new tests or more specific tests are being published to mitigate the 
deficiency of not using the target species.
8. Nematocide assessment techniques on phytopathogenic nematodes
Nematocides are usually toxic with a broad spectrum and have high volatility 
or other properties that promote migration through the soil. The use of chemical 
nematocides is increasing every day even though they have been banned [46] or 
even though alternative nematocides are being created [47, 48].
Despite the diversity of methodologies used in the assessment of nematocides, 
the results are differences between assessed compounds, and the same assessment 
must be performed several times; sometimes, the limited number of nematodes 
cultured in laboratory conditions does not allow for the necessary repetitions. In 
addition, the standardisation time of tests can be prolonged.
There is a diversity in the assessment methodologies of phytopathogenic nema-
tocides. From petri dish assessments with the challenge of the chemical being in 
relatively large spaces, which allow the nematode much movement [49], to the 
assessment in cell culture chambers [50] with an incubation and assessment period 
similar to those carried out in studies on parasitic nematodes of animals [51].
Due to the characteristics of entomopathogenic nematodes, they will always be 
a biological model with great availability to establish an assessment technique in 
a new laboratory, since the availability of specimens allows us to test a bioassay a 
greater number of times before using phytopathogenic nematodes and thus train 
the personnel who will carry out the process.
9.  Advantages of the possible use of entomopathogenic nematodes as a 
model for the biological assessment of anthelmintics
As in all tests where biological organisms are used, there are advantages and 
disadvantages, in this case between the test performed and between the organisms 
used as a biological model, so the main objective is to strengthen and exploit the 
advantages. Below are some advantages and disadvantages of the possible use of 
entomopathogenic nematodes as biological models to determine the effectiveness of 
a biological or chemical nematocide of parasitic nematodes of plants or animals.
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• The short life cycle is quickly completed.
• In the right conditions they reproduce all year round.
• Short life span.
• Known and simple anatomy.
• Abundant progeny.
• Simple and economical cultivation.
• It can be maintained for long periods in the laboratory.
• Several strains can be easily maintained in a small space.
• Constant motility with little stimulus.
• They are cosmopolitan.
• They live in the rhizosphere in more than one of their stages of the biologi-
cal cycle.
• Isolation and identification are relatively fast, inexpensive and do not require 
much training.
Disadvantages
• Relatively simple anatomy.
• Possible problem due to the type of feeding in its different stages of 
development.
• It is not possible to assess bioavailability and organic toxicity.
• It could only be used for standardisation of tests.
• The toxicity to entomopathogenic nematodes is probably not similar to that of 
parasitic nematodes.
• The differences in their anatomy and physiology should be considered in 
studies.
10. Conclusions
Currently, there is an urgent demand for the development of new anthelmintic 
drugs due to various circumstances; reaching their generation and assessment is not 
a short route and requires many economic resources; every time there has been the 
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need for them, it has been solved. However, the assessment of the product or the 
new drug in controlled or field conditions is extremely complicated.
Research is required for continuous improvement in the management of 
parasitic nematodes, emphasising the reduction of the use of chemotherapeutics 
and the development of resistance to anthelmintics, for which viable options are 
required for the assessment of this resistance. Entomopathogenic nematodes offer 
an opportunity that favours these aspects, in addition to helping to understand the 
interactions of these chemicals with the rhizosphere and the environment in general 
once they are excreted by animals.
Complications in the assessment of new drugs can be analysed in various ways; 
however, this chapter proposes an alternative solution for the lack of target nema-
todes (human or animal parasites) in sufficient quantity and in the biological stage 
of the nematodes in which the assessment is desired. Entomopathogenic nematodes, 
due to their characteristics, are an alternative to perform the assessments of new 
drugs on nontarget nematodes that even allow generating populations resistant to a 
chemical product to assess a new drug, combinations of them or to simulate activi-
ties that limit dispersion of the resistance.
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